InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Klausner Richard, Président Exécutif. Insider active across 2 companies, notably Lyell Immunopharma, Inc.. Aggregated, 5 filings have been recorded. Split: 1 buy · 2 sells. Total volume traded: €281k. Activity tracked since 23 September 2022. The latest transaction was filed on 14 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Klausner Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
158,000 股@ US$0.600931.1% 占其流量Common StockSEC:0001415889-25-008540:0
标准退出：2025年6月12日 (T+90)
58,020 股@ US$2.2843.2% 占其流量Common StockSEC:0001209191-23-046267:0
11,100 股@ US$6.400125.7% 占其流量Common StockSEC:0001209191-22-051379:0
3,765,842 股Common StockSEC:0001209191-21-042798:0
253 股Common StockSEC:0001127602-16-038840:0
5 条申报中的 5 条
About Klausner Richard
Richard Klausner is the Executive Chairman of Lyell Immunopharma, Inc. He plays a key role in the strategic direction of the company, bringing his expertise in biotechnology and drug development. His role as a board member includes overseeing performance and evaluating initiatives aimed at enhancing innovation and research. He ensures that Lyell Immunopharma meets its performance and innovation objectives.
